Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
J Am Acad Dermatol ; 83(1): 17-30, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32244016

ABSTRACT

In the second article in this continuing medical education series, we review the treatment of leprosy, its immunologic reactions, and important concepts, including disease relapse and drug resistance. A fundamental understanding of the treatment options and management of neuropathic sequelae are essential to reduce disease burden and improve patients' quality of life.


Subject(s)
Leprosy/complications , Leprosy/drug therapy , Anti-Bacterial Agents/therapeutic use , Cost of Illness , Drug Resistance, Bacterial , Drug Therapy, Combination , Female , Humans , Leprosy/immunology , Leprosy/pathology , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Quality of Life , Recurrence
2.
J Am Acad Dermatol ; 83(1): 1-14, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32229279

ABSTRACT

Leprosy, also known as Hansen's disease, is a curable infectious disease that remains endemic in >140 countries around the world. Despite being declared "eliminated" as a global public health problem by the World Health Organization in the year 2000, approximately 200,000 new cases were reported worldwide in 2017. Widespread migration may bring leprosy to nonendemic areas, such as North America. In addition, there are areas in the United States where autochthonous (person-to-person) transmission of leprosy is being reported among Americans without a history of foreign exposure. In the first article in this continuing medical education series, we review leprosy epidemiology, transmission, classification, clinical features, and diagnostic challenges.


Subject(s)
Leprosy/diagnosis , Diagnosis, Differential , Endemic Diseases , Global Health , Humans , Incidence , Leprosy/classification , Leprosy/epidemiology , Leprosy/microbiology , Prevalence
3.
Int J Surg Case Rep ; 44: 152-156, 2018.
Article in English | MEDLINE | ID: mdl-29501933

ABSTRACT

INTRODUCTION: Pyoderma gangrenosum is a chronic neutrophilic dermatosis which can occur following trauma or surgery and can mimic infection. Surgical intervention can lead to progression of disease. PRESENTATION OF CASES: This case series describes 3 cases of post-surgical pyoderma gangrenosum with delayed diagnosis from two large medical centers. DISCUSSION: Epidemiology, pathogenesis, clinical and histopathologic presentation, and management of post-surgical pyoderma gangrenosum are discussed with a review of the literature. CONCLUSION: Post-surgical pyoderma gangrenosum (PSPG) can mimic ulcerative disorders including bacterial infection. The diagnosis should be suspected in post-operative wounds with negative bacterial cultures which progress despite broad-spectrum antibiotics and surgical debridement. Recognizing the clinical features of PSPG is fundamental to prevent severe destruction and deformity.

5.
Am J Dermatopathol ; 37(12): 875-81; quiz 882-4, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26588332

ABSTRACT

BACKGROUND: The occurrence of lichenoid keratosis (LK) on the face is not well characterized, and the histopathologic distinction between LK and lupus erythematosus (LE) occurring on the face is often indeterminate. The authors aimed to describe differences between LE and LK occurring on the face by hematoxylin and eosin alone. METHODS: Cases of LK and LE were obtained using computer-driven queries. Clinical correlation was obtained for each lupus case. Other diagnoses were excluded for the LK cases. Hematoxylin and eosin-stained sections were reviewed. RESULTS: Forty-five cases of LK and 30 cases of LE occurring on the face were identified. Shared features included follicular involvement, epidermal atrophy, pigment incontinence, paucity of eosinophils, and basket-weave orthokeratosis. Major differences between LK and LE, respectively, included perivascular inflammation (11%, 90%), high Civatte bodies (44%, 7%), solar elastosis (84%, 33%), a predominate pattern of cell-poor vacuolar interface dermatitis (7%, 73%), compact follicular plugging (11%, 50%), hemorrhage (22%, 70%), mucin (0%, 77%), hypergranulosis (44%, 17%), and edema (7%, 60%). A predominate pattern of band-like lichenoid interface was seen more commonly in LK as compared with LE (93% vs. 27%). CONCLUSIONS: The authors established the occurrence of LK on the face and identified features to help distinguish LK from LE. Follicular involvement, basket-weave orthokeratosis, pigment incontinence, paucity of eosinophils, and epidermal atrophy were not reliable distinguishing features. Perivascular inflammation, cell-poor vacuolar interface, compact follicular plugging, mucin, hemorrhage, and edema favored LE. High Civatte bodies, band-like lichenoid interface, and solar elastosis favored LK.


Subject(s)
Face/pathology , Lichenoid Eruptions/pathology , Lupus Erythematosus, Discoid/pathology , Adult , Aged , Aged, 80 and over , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Young Adult
6.
Dermatol Clin ; 33(3): 541-62, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26143431

ABSTRACT

Leprosy and tuberculosis are chronic mycobacterial infections that elicit granulomatous inflammation. Both infections are curable, but granulomatous injury to cutaneous structures, including cutaneous nerves in leprosy, may cause permanent damage. Both diseases are major global concerns: tuberculosis for its high prevalence and mortality, and leprosy for its persistent global presence and high rate of neuropathic disability. Cutaneous manifestations of both leprosy and tuberculosis are frequently subtle and challenging in dermatologic practice and often require a careful travel and social history and a high index of suspicion.


Subject(s)
Leprosy, Lepromatous/diagnosis , Leprosy, Tuberculoid/diagnosis , Lupus Vulgaris/diagnosis , Skin/pathology , Antitubercular Agents/therapeutic use , Humans , Leprostatic Agents/therapeutic use , Leprosy/diagnosis , Leprosy/drug therapy , Leprosy, Lepromatous/drug therapy , Leprosy, Tuberculoid/drug therapy , Lupus Vulgaris/drug therapy , Tuberculosis, Cutaneous/diagnosis , Tuberculosis, Cutaneous/drug therapy , Tuberculosis, Miliary/diagnosis , Tuberculosis, Miliary/drug therapy
9.
South Med J ; 104(10): 689-94, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21941157

ABSTRACT

OBJECTIVES: To evaluate the occurrence of relapse of multibacillary leprosy after multi-drug treatment including daily rifampin. METHODS: A retrospective review was performed utilizing data from the National Hansen's Disease Program (NHDP) on patients with leprosy treated and followed from 1988-1997 who received multi-drug therapy including daily rifampin. The occurrence of relapse in this cohort was measured, and demographic data and various clinical variables were also gathered. RESULTS: Ultimately, 158 cases fulfilled the eligibility criteria. 77% of cases were multibacillary patients and were treated with 2 or 3 drug protocols at rates of 36% and 35% before and after 1992, respectively. Only one case of relapse was found, and this patient underwent 2-drug therapy versus 3-drug therapy. CONCLUSION: These data are remarkable for the absence of relapse with daily rifampin, as contrasted with the published experience using the WHO protocol with monthly rifampin.


Subject(s)
Leprostatic Agents/administration & dosage , Leprosy/drug therapy , Rifampin/administration & dosage , Administration, Cutaneous , Administration, Oral , Adult , Aged , Biopsy , Clofazimine/administration & dosage , Dapsone/administration & dosage , Drug Administration Schedule , Drug Therapy, Combination , Female , Follow-Up Studies , Health Surveys , Humans , Leprosy/epidemiology , Leprosy/pathology , Leprosy/prevention & control , Male , Medical Records , Middle Aged , Retrospective Studies , Secondary Prevention , Treatment Outcome , United States/epidemiology
10.
Case Rep Oncol ; 2(1): 24-29, 2009 Feb 26.
Article in English | MEDLINE | ID: mdl-20740141

ABSTRACT

Recurrent lobular breast carcinoma manifesting as a cutaneous neck nodule in a woman, 14 years after successful chemotherapy, illustrates the importance of following at-risk patients with a high level of clinical suspicion. This case emphasizes the value of combining clinical findings with appropriate histopathologic and immunohistochemical analysis when evaluating a cutaneous lesion in such a patient.

SELECTION OF CITATIONS
SEARCH DETAIL
...